| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LIFX | Common Stock | Other | $0 | -571K | -18.91% | $0.00 | 2.45M | Jun 28, 2023 | Direct | F1, F2 |
| holding | LIFX | Common Stock | 30K | Jun 28, 2023 | Held by ICCA Labs, LLC | F3, F4 |
| Id | Content |
|---|---|
| F1 | Certain shares of the Issuer's common stock underlying Chess Depositary Interests ("CDIs") held by the Reporting Person were previously pledged as collateral to secure certain personal indebtedness of the Reporting Person under a loan facility with a third-party lender. On June 28, 2023, the Reporting Person transferred 1,711,661 CDIs (equivalent to 570,554 shares) to the lender to satisfy the full outstanding amount under the loan as required by the loan documentation. |
| F2 | Includes 1,115,999 shares of the Issuer's common stock underlying 3,347,995 CDIs. The CDIs are traded on the Australian Securities Exchange (the "ASX") and are held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Also includes 68,023 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting. |
| F3 | Represents shares of the Issuer's common stock underlying 89,880 CDIs. |
| F4 | The Reporting Person is a member of ICCA Labs, LLC, an entity that holds an aggregate of 133,408 shares of the Issuer's common stock underlying 400,224 CDIs. The number of shares reported herein by the Reporting Person represents his proportionate ownership interest in ICCA Labs, LLC. |
Exhibit 24 - Power of Attorney